Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice

被引：0
|
作者：
T. Thomas
S. Horlait
J. D. Ringe
A. Abelson
D. T. Gold
P. Atlan
J. L. Lange
机构：
[1] University Hospital of Saint-Etienne,INSERM U1059, Rheumatology Department
[2] Warner Chilcott,Medizinische Klinik IV (Osteology, Rheumatology), Klinikum Leverkusen
[3] University of Cologne,undefined
[4] Cleveland Clinic Foundation,undefined
[5] Duke University Medical Center,undefined
[6] Procter & Gamble,undefined
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Bisphosphonates; Clinical fractures; Glucocorticoid-induced osteoporosis; Risk reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 269
页数：6
相关论文
共 50 条
  • [21] Glucocorticoid-induced osteoporosis
    Reid, IR
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (02) : 279 - 298
  • [22] Glucocorticoid-induced osteoporosis
    Adachi, JD
    Ioannidis, G
    DRUG DEVELOPMENT RESEARCH, 2000, 49 (03) : 120 - 134
  • [23] Glucocorticoid-induced osteoporosis
    Sambrook, Philip N.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2008, 11 (04) : 381 - 385
  • [24] Treatment of glucocorticoid-induced osteoporosis
    Mazziotti, Gherardo
    Giustina, Andrea
    Canalis, Ernesto
    Bilezikian, John P.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2009, 1 (01) : 27 - 34
  • [25] Glucocorticoid-Induced Osteoporosis and Osteonecrosis
    Weinstein, Robert S.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2012, 41 (03) : 595 - +
  • [26] Glucocorticoid-induced osteoporosis update
    Adami, Giovanni
    Seag, Kenneth G.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (04) : 388 - 393
  • [27] Glucocorticoid-induced osteoporosis: an update
    Compston, Juliet
    ENDOCRINE, 2018, 61 (01) : 7 - 16
  • [28] Update on Glucocorticoid-Induced Osteoporosis
    Maricic, Michael
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2011, 37 (03) : 415 - +
  • [29] Glucocorticoid-induced osteoporosis: an update
    Juliet Compston
    Endocrine, 2018, 61 : 7 - 16
  • [30] Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk
    Kenanidis, Eustathios
    Potoupnis, Michael E.
    Kakoulidis, Panagiotis
    Leonidou, Andreas
    Sakellariou, Grigorios T.
    Sayegh, Fares E.
    Tsiridis, Eleftherios
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1035 - 1053
12345